Background: Hypokalemia is considered when the serum potassium level is less than 3.5 mmol/L. Clinical research indicates that hypokalemia affects 20% of hospitalized patients, and in 24% of these cases, inadequate interventions result in life-threatening complications. At present, there is no research available on the prevalence, management, and outcomes of hypokalemia in hospitalized patients, which justifies the need for this study. Aim: The study aimed to examine the prevalence of hypokalemia and the effectiveness of its management in hospitalized patients within the internal medicine department, in relation to the knowledge of doctors and resident physicians. Materials and Methods: This hospital-based retrospective study included a total of 553 cases of patients hospitalized in the Internal Medicine Department of the Mongolia Japan Hospital between January 2024 and August 2024. Patients with a potassium level of <3.5 mmol/L were diagnosed with hypokalemia, and the effectiveness of potassium replacement therapy was evaluated according to the method of supplementation employed. Results: The prevalence of hypokalemia among hospitalized patients in the Internal Medicine Department was 9.8% (54 cases). Based on the study criteria, 42 cases of hypokalemia were selected for further analysis, and a total of 118 potassium replacements were performed through oral, intravenous, and mixed methods. Following potassium replacement therapy, 37.3% (44) of patients achieved normalized potassium levels, while 62.7% (74) still had persistent hypokalemia. Conclusion According to the study results, the prevalence of hypokalemia among hospitalized patients in the Internal Medicine Department is 9.8%. The method of potassium replacement and the severity of hypokalemia do not impact the normalization of potassium levels, with the critical factor being the proper dosage of supplementation. The knowledge of doctors and resident physicians regarding hypokalemia is insufficient, and there is a need to implement guidelines and protocols for potassium replacement therapy in daily clinical practice.

Background: According to the World Health Organization (WHO), 6.7 million people die annually due to air pollution caused by solid fuel use, with the majority of deaths resulting from respiratory diseases and cardiovascular conditions. In Mongolia, air pollution ranks as the fourth leading risk factor contributing to mortality, following hypertension, diabetes, and other major health risks. Although there have been numerous studies on outdoor air pollution in Mongolia, research linking indoor air pollution at the household level with the health status of residents remains limited. Aim: To compare indoor PM2.5 concentrations in households of Ulaanbaatar and Darkhan and examine their association with hypertension during the winter season. Materials and Methods: The study was conducted during November and December 2023, and January 2024, involving 240 households in Ulaanbaatar and Darkhan. Indoor PM2.5 concentrations were measured using Purple Air real-time sensors continuously for 24 hours over approximately one month. After measuring indoor air pollution, individuals aged 18–60 years living in the selected households were recruited based on specific inclusion criteria. Blood pressure was measured three times and the average value was recorded. Information on respiratory illnesses was collected through structured questionnaires. Statistical analysis was performed using STATA version 19.0. Results: A total of 241 households participated in the study, with 116 from Ulaanbaatar and 125 from Darkhan. Of the participants, 46.5% were male and 53.5% were female. In terms of housing type, 96 households (39.8%) lived in gers, 97 (40.2%) lived in stove-heated houses, and 48 (19.9%) lived in apartments. Among all participants, 66.0% (n=159) had hypertension and 34.0% (n=79) had normal blood pressure. Among participants aged over 40, 69.9–88.5% had hypertension, which is statistically significantly higher compared to younger individuals (p=0.0001). By body mass index, 75.3% (n=72) of overweight individuals and 78.4% (n=58) of obese participants had hypertension, showing a statistically significant difference compared to participants with normal weight (p=0.0001). The 24-hour average concentration of indoor PM2.5 was measured using the Purple Air device, and the levels in gers and stove-heated houses exceeded the limit set by the MNS 4585:2025 standard (37.5 µg/m³) Conclusion This study identified a relationship between environmental factors, such as air pollution and housing type, and the prevalence of hypertension. The indoor PM2.5 concentration in gers and stove-heated houses was above the standard limit, indicating a negative impact on the health of those residents. Furthermore, the high prevalence of hypertension among participants over the age of 40 and those who are overweight suggests a possible link to lifestyle and environmental conditions.

Introduction: 16% of the world's 8 billion people, or more than 1.3 billion, are people with special needs or people with disabilities. Of these, there are unofficial studies that show that there are about 650 million people with disabilities in Asian countries. [1] One of the most common problems faced by people with special needs is that disability service organizations, especially pharmacies, do not have access to complete information on their necessary medications.
According to the 2019 data of the National Statistics Committee [4] in our country, 3.4 percent of the total population or 107.6 thousand are citizens with special needs. Article 1.1 of the Law "On the Rights of Persons with Disabilities" [5] provides for the equal rights of persons with disabilities to participate in social relations, to ensure and implement them, to provide an accessible environment, to create conditions, housing, public buildings, roads, public transport, and information., communication technology is included as being accessible to people with disabilities. However, health and pharmacy services for people with special needs are very challenging.
The main basis of this research work is to make pharmacy services easier for people with special needs, especially people with speech, hearing, visual, mental, and motor disabilities, and to identify and solve problems. Methods: The research was carried out in a one-moment model. Based on the General Department of Development of People with Disabilities, data was collected by questionnaire using the minimum sample size calculation, which was calculated as 478 people per 1000 population. Statistical analysis was carried out using SPSS-23 software.
Our survey was conducted between November to December 1, 2022 using a snapshot model. Processing of results was carried out using survey data processing. Conclusion
1. According to the 2019 data of the National Statistics Committee, 3.4 percent or 107.6 thousand of the total population of our country are citizens with special needs. This information has not been updated for 2021-2022.
Out of a total of 478 people in the survey, 54% were male, while 42.8% of the respondents were 20-30 years old. 48.8% of citizens use pharmacies independently, 42.4% with the help of a guardian, and 8.8% of other citizens use pharmacies. The lack of understanding of drug information on prescription forms affects the physician's prescription, drug information, visual and hearing impairments, and misunderstandings.
2. People with speech, hearing, visual, mental, and motor disabilities face the biggest problem in using the pharmacy. Therefore, it is a priority to make certain innovative changes in order to make pharmacy operation* equal to citizens. These include: Prescription forms can be read using technology such as Qr and AR on the phone, delivering medication instructions and information in audio form to people with visual and mental disabilities, providing more clear and understandable information to people with speech and hearing disabilities identifying medications for people with visual impairments, and using drugs correctly. We believe that suggestions and solutions are needed, such as placing names and instructions in braille on product labeling and packaging, implementing stairs and doors for people in wheelchairs or with mobility impairments in accordance with standards in all buildings, and providing seats for stairwells between floors. In most cases, it takes 10-20 minutes for people with disabilities to visit a pharmacy. Some citizens are experiencing delays in services for up to an hour. It can be seen that spending a lot of time to visit a pharmacy is difficult for citizens.
In order to solve this problem, under the supervision of a manager and a pharmacist, a post-graduate student of "Pharmacy" of the "University of Pharmaceutical Sciences" should be created to provide advice and information to citizens and reduce the burden.

Background: Vitamins are nutrients essential for human health. They act as coenzymes that help trigger important chemical reactions necessary for energy production. Reference values for vitamins help physicians evaluate the health status of patients and make clinical decisions. The aim of this study was to determine the mean values and reference intervals for some water-soluble vitamins of Mongolian adults. Materials and Methods: Three hundred and forty healthy adults (170 males and 170 females) of 17 to 69 years of age were selected for the study based on CLSI C28-P3 criteria Defining, establishing & Verifying reference interval in the clinical laboratory; Proposed Guidelines. The study was approved by the Resolution No.76 of 2018 of the Medical Ethics Review Committee of the Ministry of Health. Informed consents were taken from the selected individuals. Morning blood samples of the participants were collected under aseptic conditions. Levels of vitamins B₆, B₉, B₁₂ and vitamin C were measured using a high performance liquid chromatography method. The lower- and upper reference limits were defined as the 2.5th and 97.5th percentiles, respectively. The data were analyzed using SPSS and Excel programs. Results: The mean blood level of vitamin C was 11.88 mg/L (95% CI 10.47-13.29) for men and 9.62 mg/L (95% CI 8.11-11.13) for women. The calculated reference interval for males was 1.40-19.40 mg/L and 1.17-18.04 mg/L for females. The mean concentration of vitamin B₁₂ in the blood of males was 938.45 ng/L (95% CI 747.22-1129.68) and that of females was 864.03 ng/L (95% CI 603.81-1124.25). The reference interval for vitamin B₁₂ was 233.03-1597.00 ng/L in men and 132.45-1623.86 ng/L in women. The mean level of vitamin B₉ was 8.47 ng/mL (95% CI 5.64-11.30) for men and 6.91 ng/mL (95% CI 4.89-8.93) for women. The calculated reference interval for this vitamin in males was 1.04-24.74 ng/mL and that in females was 1.04-21.46 ng/mL. As for vitamin B₆, the mean concentration for men was 44.42 ng/mL (95% CI 37.01-51.83) and for women was 34.67 ng/mL (95% CI 29.97-39.39) with the reference intervals of 5.90-79.02 ng/mL for men and 5.27-61.72 ng/mL for women. Conclusion The reference values for vitamins B₆, B₉, B₁₂ and vitamin C of Mongolian adults do not differ significantly from those observed in other populations. The calculated reference intervals can be used in the practice of health laboratories.

BACKGROUND. Chronic rhino-sinusitis (CRS) is a common inflammatory disease of the nose and paranasal sinuses, especially after virus infections. It has a significant impact on patients’ quality of life. We aimed to evaluate the clinical value of low-level laser therapy (LLLT) forpediatric chronic rhino-sinusitis. METHODS. 30 patients 6-15 years old with CRS were divided into two groups: T1 were treated twice a week and T2 were treated five times a week for 2 treatment sessions within 2 weeks. Laser irradiation was delivered on 12 points over each maxillary and frontal sinuses with 30 seconds and the total treatment duration was 180 seconds. The evaluation was performed by a total symptom score based on SNOT-22 questionnaires of pre and after treatments. RESULTS. The total symptom scoreimproved significantly (p<0.15) in 27 cases. CONCLUSION. This study indicates that LLLT applied for 4 weeks improves symptoms in patients with CRS. LLLT is one of the most cost-efficient and painless treatment methods for pediatric rhino-sinusitis.